More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development
Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well.
To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030-/249.html
The USD 3.7 billion (by 2030) financial opportunity within the encapsulated cell therapies and cell encapsulation techniques market has been analyzed across the following segments:
- Type of licensing deal payment
- Upfront payment
- Milestone payment
- Therapeutic area
- Metabolic disorder
- Neurological disorder
- Ophthalmic disorder
- Oncological disorder
- Target disease indication
- Ataxia telangiectasia
- Breast cancer
- Diabetes
- Glaucoma
- Head and neck cancer
- Macular telangectasia
- Pancreatic cancer
- Parkinson’s disease
- Retinitis pigmentosa
- Type of encapsulation material used
- Alginate-based microcapsule
- Cellulose hydrogel
- Medical-grade plastic
- Red blood cell
- Key geographical region
- North America
- Europe
- Asia-Pacific and rest of the world
The Cell Encapsulationv, 2019-2030 report features the following companies, which we identified to be key players in this domain:
- ALTuCELL
- Azellon Cell Therapeutics
- Beta-Cell
- Betalin Therapeutics
- CellProtect Biotechnology
- Diatranz Otsuka
- Encellin
- EryDel
- Gloriana Therapeutics
- Living Cell Technologies
- MaxiVAX
- Neurotech Pharmaceuticals
- PharmaCyte Biotech
- Semma Therapeutics
- Sernova
Table of Contents
- Preface
- Executive Summary
- Introduction
- Current Market Landscape
- Encapsulated Cell Therapies and Encapsulation Technologies for Metabolic Disorders: Company Profiles
- Encapsulated Cell Therapies and Encapsulation Technologies for Non-Metabolic Disorders: Company Profiles
- Patent Analysis
- Clinical Trial Analysis
- Recent Partnerships
- Funding and Investment Analysis
- Grant Analysis
- Potential Strategic Partners
- Market Forecast
- Conclusion
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com
Facebook – https://www.facebook.com/RootsAnalysis
LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter – https://twitter.com/RootsAnalysis
Medium – https://medium.com/@RootsAnalysis
Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/
Quora – https://rootsanalysisinsights.quora.com/
